Matthew G. Stanton, Ph.D. - Publications

Affiliations: 
2003 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
total synthesis of biologically active and structurally novel natural products

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Methot JL, Hoffman DM, Witter DJ, Stanton MG, Harrington P, Hamblett C, Siliphaivanh P, Wilson K, Hubbs J, Heidebrecht R, Kral AM, Ozerova N, Fleming JC, Wang H, Szewczak AA, et al. Delayed and Prolonged Histone Hyperacetylation with a Selective HDAC1/HDAC2 Inhibitor. Acs Medicinal Chemistry Letters. 5: 340-5. PMID 24900838 DOI: 10.1021/Ml4004233  0.379
2009 Sankaranarayanan S, Holahan MA, Colussi D, Crouthamel MC, Devanarayan V, Ellis J, Espeseth A, Gates AT, Graham SL, Gregro AR, Hazuda D, Hochman JH, Holloway K, Jin L, Kahana J, ... ... Stanton MG, et al. First demonstration of cerebrospinal fluid and plasma A beta lowering with oral administration of a beta-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primates. The Journal of Pharmacology and Experimental Therapeutics. 328: 131-40. PMID 18854490 DOI: 10.1124/jpet.108.143628  0.311
2008 Lee AY, Paweletz CP, Pollock RM, Settlage RE, Cruz JC, Secrist JP, Miller TA, Stanton MG, Kral AM, Ozerova ND, Meng F, Yates NA, Richon V, Hendrickson RC. Quantitative analysis of histone deacetylase-1 selective histone modifications by differential mass spectrometry. Journal of Proteome Research. 7: 5177-86. PMID 19367703 DOI: 10.1021/Pr800510P  0.383
2008 Methot JL, Chakravarty PK, Chenard M, Close J, Cruz JC, Dahlberg WK, Fleming J, Hamblett CL, Hamill JE, Harrington P, Harsch A, Heidebrecht R, Hughes B, Jung J, Kenific CM, ... ... Stanton MG, et al. Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2). Bioorganic & Medicinal Chemistry Letters. 18: 973-8. PMID 18182289 DOI: 10.1016/J.Bmcl.2007.12.031  0.34
2007 Hamblett CL, Methot JL, Mampreian DM, Sloman DL, Stanton MG, Kral AM, Fleming JC, Cruz JC, Chenard M, Ozerova N, Hitz AM, Wang H, Deshmukh SV, Nazef N, Harsch A, et al. The discovery of 6-amino nicotinamides as potent and selective histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17: 5300-9. PMID 17761416 DOI: 10.1016/J.Bmcl.2007.08.023  0.362
2007 Stanton MG, Stauffer SR, Gregro AR, Steinbeiser M, Nantermet P, Sankaranarayanan S, Price EA, Wu G, Crouthamel MC, Ellis J, Lai MT, Espeseth AS, Shi XP, Jin L, Colussi D, et al. Discovery of isonicotinamide derived beta-secretase inhibitors: in vivo reduction of beta-amyloid. Journal of Medicinal Chemistry. 50: 3431-3. PMID 17583334 DOI: 10.1021/jm070272d  0.328
2002 Crimmins MT, Stanton MG, Allwein SP. Asymmetric total synthesis of (-)-laulimalide: exploiting the asymmetric glycolate alkylation reaction. Journal of the American Chemical Society. 124: 5958-9. PMID 12022826 DOI: 10.1021/Ja026269V  0.414
Show low-probability matches.